WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhou, Xuan ^a   Ren, Yu ^a   Liu, Aiqin ^a   Jin, Rui ^a   Jiang, Qingping ^b   Huang, Yuanyuan ^a   Kong, Lingping ^a   Wang, Xudong ^a   Zhang, Lun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 BROMO 2 PYRIDINYL) 2 CYANO N (1 PHENYLETHYL)ACRYLAMIDE; APOPTOSIS REGULATORY PROTEIN; CISPLATIN; MICRORNA; MIRN21 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; PYRIDINE DERIVATIVE; RNA BINDING PROTEIN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TIMP3 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TYRPHOSTIN;

ANIMAL; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; METABOLISM; MOUSE; MOUTH NEOPLASMS; NUDE MOUSE; PHOSPHORYLATION; TUMOR CELL LINE; UPREGULATION; XENOGRAFT;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; MICRORNAS; MOUTH NEOPLASMS; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; PYRIDINES; RNA-BINDING PROTEINS; STAT3 TRANSCRIPTION FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TYRPHOSTINS; UP-REGULATION;

EID: 84922601431     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07461     Document Type: Article

References (37)

1. Pulte, D. & Brenner, H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 15, 994-1001 (2010).
2. Lam, L., Logan, R. M. & Luke, C. Epidemiological analysis of tongue cancer in South Australia for the 24-year period, 1977-2001. Aust. Dent. J. 51, 16-22 (2006).
3. Cullen, K. J. et al. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res. 63, 8097-8102 (2003).
4. Jacobs, C. et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 10, 257-263 (1992).
5. Shen, D. W., Pouliot, L. M.,Hall, M. D.&Gottesman, M. M. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 64, 706-721 (2012).
6. Giraud, S. et al. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem. 277, 8004-8011 (2002).
7. Nakashima, K. et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 284, 479-482 (1999).
8. Pan, Y., Zhou, F., Zhang, R. & Claret, F. X. STAT3 inhibitor Stattic exhibits potent antitumor activity and induces chemo-and radio-sensitivity in nasopharyngeal carcinoma. PLoS One. 8, e54565 (2013).
9. Duan, Z. et al. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res. 12, 5055-5063 (2006).
10. Dai, Y., Rahmani, M., Pei, X. Y., Dent, P. & Grant, S. Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and-independent mechanisms. Blood. 104, 509-518 (2004).
11. Chiu, H. C. et al. Suppression of STAT3 activity sensitizes gefitinib-resistant non small cell lung cancer cells. Biochem Pharmacol. 81, 1263-1270 (2011).
12. Gu, F. et al. Expression of STAT3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. Oncol Rep. 23, 671-676 (2010).
13. He, L. & Hannon, G. J.MicroRNAs: small RNAs with a big roll in gene regulation. Nature Gen. 5, 522-531 (2004).
14. Yang, S. M. et al. MiR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology. 306, 162-168 (2013).
15. Zhu, W. et al. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol. 69, 723-731 (2012).
16. Rozovski, U. et al. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Mol Cancer. 12, 50 (2013).
17. Wang, Y. Y. et al. MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth. CNS Neurosci Ther. 18, 722-728 (2012).
18. Bourguignon, L. Y., Earle, C., Wong, G., Spevak, C. C. & Krueger, K. Stem cell marker (Nanog) and STAT3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene. 31, 149-160 (2012).
19. Löffler, D. et al. Interleukin-6 dependent survival of multiple myeloma cells involves the STAT3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood. 110, 1330-1333 (2007).
20. Ferrajoli, A. et al. WP1066 disrupts Janus kinase-2 and induces caspase dependent apoptosis in acute myelogenous leukemia cells. Cancer Res. 67, 11291-9 (2007).
21. Iwamaru, A. et al. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene. 26, 2435-2444 (2007).
22. Bhattacharya, S., Ray, R. M. & Johnson, L. R. STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem J. 392, 335-344 (2005).
23. Chang, Q. et al. The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia. 15, 848-862 (2013).
24. Kiuchi, N. et al. STAT3 is required for the gp130-mediated full activation of the cmyc gene. J Exp Med. 189, 63-73 (1999).
25. Epling-Burnette, P. K. et al. Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colonystimulating factor-delayed apoptosis in human neutrophils. J Immunol. 166, 7486-7495 (2001).
26. Leslie, K. et al. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res. 66, 2544-2552 (2006).
27. Xu, Q. et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 24, 5552-5560 (2005).
28. Konnikova, L., Simeone, M. C., Kruger, M. M., Kotecki, M. & Cochran, B. H. Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res. 65, 6516-6520 (2005).
29. Ji, T. et al. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer. Cancer Lett. 341, 231-239 (2013).
30. Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L. & Struhl, K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell. 39, 493-506 (2010).
31. Ren, Y. et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer. 10, 27 (2010).
32. Ren, Y. et al. Co-delivery of as-miR-21 and 5-FU by poly (amidoamine) dendrimer attenuates human glioma cell growth in vitro. J Biomater Sci Polym Ed. 21, 303-314 (2010).
33. Moral, M. & Paramio, J.M. Akt pathway as a target for therapeutic intervention in HNSCC. Histol Histopathol. 23, 1269-1278 (2008).
34. Zhou, X. et al. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo. Oncol Rep. 5, 2173-80 (2014).
35. Lederle, W. et al. IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines. Int J Cancer. 128, 2803-2814 (2011).
36. Zhou, X. et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest. 90, 144-155 (2010).
37. Han, L. et al. Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo. Hum Gene Ther. 4, 417-426 (2010).